Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment

Methods Enzymol. 1995:262:171-85. doi: 10.1016/0076-6879(95)62017-6.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal
  • Base Sequence
  • Chromatography, Affinity / methods
  • Chromatography, Ion Exchange / methods
  • Cloning, Molecular
  • Crystallization
  • DNA / metabolism
  • DNA Primers
  • Electrophoresis, Polyacrylamide Gel / methods
  • Enzyme Inhibitors / metabolism*
  • Escherichia coli
  • HIV Reverse Transcriptase
  • HIV-1 / enzymology*
  • Humans
  • Immunoglobulin Fab Fragments
  • Macromolecular Substances
  • Molecular Sequence Data
  • RNA-Directed DNA Polymerase / chemistry*
  • RNA-Directed DNA Polymerase / isolation & purification*
  • RNA-Directed DNA Polymerase / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism
  • Substrate Specificity
  • Templates, Genetic

Substances

  • Antibodies, Monoclonal
  • DNA Primers
  • Enzyme Inhibitors
  • Immunoglobulin Fab Fragments
  • Macromolecular Substances
  • Recombinant Proteins
  • DNA
  • HIV Reverse Transcriptase
  • RNA-Directed DNA Polymerase